Temporarily Closed. New orders are paused while we resolve an unforeseen operational issue. Existing orders will still be fulfilled.

Thymosin Alpha 1

Accelerating

Thymosin Alpha 1 appears in 1,074 indexed publications going back to 1978, including 23 in the past twelve months. 33 registered trials appear on ClinicalTrials.gov.

1,074
Indexed publications
23
Past 12 months, against 17 the year before
33
Registered clinical trials
36
Monthly readers on Wikipedia, down 23%
Research Activity

Publication history

How much work has been indexed each year, from Europe PMC. Momentum is measured over a trailing twelve months rather than calendar years, so a partial current year never reads as a decline.

20152026

Publications per year. The final bar is the current year, still in progress.

Indexed publications per year
201529
201612
201712
201826
201912
202025
202116
202217
202330
202413
202516
202622
Public Attention

Who is looking it up

Monthly readers of the Thymosin Alpha 1 article on English Wikipedia. An independent measure of curiosity, which often moves quite differently from the evidence.

2025-122026-09
Clinical Trials

The registered pipeline

Early Phase 1
0
Phase 1
3
Phase 2
10
Phase 3
3
Phase 4
2

Phase distribution across the most recently updated registered trials.

References

Most recent work

The newest indexed records mentioning Thymosin Alpha 1, listed by publication date. Titles are shown as published and link to their source. Inclusion here is a record of what exists, not a judgement of what it shows.

  1. 2026-03-23·Virulence

    Thymosin α1-induced secretion of the IL-15/RA complex by THP-1-derived dendritic cells restrains HIV latency <i>in vitro</i>

    Chen C, Xun J, Wang J et al.

  2. 2026-10-08·Veterinary microbiology

    A novel porcine interleukin-2-interferon-α-thymosin α1 tripartite fusion protein confers antiviral activity against pseudorabies virus

    Zhang W, Yang X, Zhang M et al.

  3. 2026-08-26·European journal of pharmacology

    Thymosin α-1 in cancer therapy: Immunomodulatory mechanisms, clinical applications, and translational perspectives

    Chuang SC, Hung PC, Rethi L et al.

  4. 2026-09-19·Pharmaceuticals (Basel, Switzerland)

    Clinical Applications and Evidence Landscape of Thymosin Alpha 1 as an Immunomodulatory Adjunct in Cancer Care: A Scoping Review

    Kim SD, Kim KR, Kim DH et al.

  5. 2026-09-09·The Cochrane database of systematic reviews

    Thymosin-ɑ1 for people with chronic hepatitis B

    Naing C, Ni H, Aung HH et al.

  6. 2026-05-28·Journal of traditional and complementary medicine

    A prospective clinical study on the effectiveness of <i>Phellinus igniarius</i> decoction in treating immune dysfunction in colorectal cancer patients following chemfotherapy

    Zhang H, Li W, Hu D et al.

  7. 2026-09-03·Advanced science (Weinheim, Baden-Wurttemberg, Germany)

    Thymosin Alpha-1 Provides Direct Neuroprotection by Engaging the Orexin Receptor HCRTR1 to Suppress Neuronal Necroptosis

    Kang X, Wang S, Zhang L et al.

  8. 2026-09-01·Cancer research

    Thymosin Alpha-1 Restores Chemotherapy-Induced Antitumor Immunity by Chaperoning a MicroRNA Ligand of TLR7 in Dendritic Cells

    Wei Y, Chen J, Zhang Y et al.

In the Catalogue

Thymosin Alpha 1 available from Polaris Research

Supplied as research materials for laboratory use. Free express delivery Australia wide.

Sources

Publication data from Europe PMC. Clinical trial data from ClinicalTrials.gov, U.S. National Library of Medicine. Public attention from Wikimedia pageview data. Evidence grades from reptides.co. We report counts and dates from these sources and link every record to its origin, we do not summarise findings. Last synced 2026-10-25.